Neural Tube Defects
27
3
7
13
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.7%
1 terminated out of 27 trials
92.9%
+6.4% vs benchmark
7%
2 trials in Phase 3/4
23%
3 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (27)
In-Utero Endoscopic Correction of Spina Bifida
Fetoscopic Repair of Isolated Fetal Spina Bifida
Folic Acid Salt Study (FISFA Zambia)
Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study
Safety and Efficacy of Devices Used in Fetoscopic Neural Tube Defect Repair Cases
In Utero Fetoscopic Repair Program for Sacral Myelomeningoceles and Mye-LDM
Using Iodized Salt to Improve Serum Folate, B12 and Iron Levels
Fetoscopic Neural Tube Defect Repair
Minimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study
Birth Outcomes In Eswatini After Transition To Dolutegravir-Based Treatment
Salt-FA to Increase Folate Levels
Assessing Folic Acid in High-Risk Pregnancy for Neural Tube Defects
Feasibility, Acceptability and Directional Signal Effect on Blood Folate Levels of Iodized Salt Fortified With Folic Acid: Clinical Study
Influence of "Espresso" on Adsorption of Myo-inositol
Automated Myocardial Performance Index Using Samsung HERA W10
Could Bisphenol-A Have a Role in the Etiology of Neural Tube Defects
Metals/Vitamins Levels in NTD
Short- Term Follow up Of Neonates Born With Neural Tube Defect
Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele
Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Neural Tube Defects?